Differentiating COVID-associated myocarditis from other Diseases: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 10: | Line 10: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
COVID-19-associated myocarditis must be differentiated from [[ | COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac [[biomarkers]], [[ventricular dysfunction]] such as including [[COVID-19-associated myocardial infarction|Acute Coronary Syndrome]], [[COVID-19-associated stress cardiomyopathy|Stress-induced cardiomyopathy]] ([[Takotsubo cardiomyopathy]]) and [[COVID-19-associated heart failure|Heart failure]]. | ||
<small> | <small> | ||
{| | {| | ||
Line 31: | Line 30: | ||
!<small>Echocardiography</small> | !<small>Echocardiography</small> | ||
!<small>CT scan and CMR</small> | !<small>CT scan and CMR</small> | ||
|- | |||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocarditis]] | |||
| style="background: #F5F5F5; padding: 5px;" |✔ | |||
| style="background: #F5F5F5; padding: 5px;" |✔ | |||
| style="background: #F5F5F5; padding: 5px;" |- | |||
| style="background: #F5F5F5; padding: 5px;" |✔ | |||
| style="background: #F5F5F5; padding: 5px;" |✔ | |||
| style="background: #F5F5F5; padding: 5px;" |✔ | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
*[[Pericardial effusion]] may be detectable | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as bundle-branch blocks or atrioventricular conduction delays) | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left ventricular dilation and normal wall thickness might be seen. | |||
*[[Pericardial effusion]] may be be seen. | |||
| style="background: #F5F5F5; padding: 5px;" | | |||
*CMR: T2-weighted edema imaging shows the presence of “acute myocardial inflammation”. "[[Late gadolinium enhancement (LGE)]] imaging” can demonstrate myocardial damage. | |||
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]]s level | |||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]] | |style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]] | ||
Line 88: | Line 105: | ||
*CT: Bilateral [[ground-glass opacities]] | *CT: Bilateral [[ground-glass opacities]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
|- | |- | ||
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]] | |style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]] |
Revision as of 08:00, 24 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]
Overview
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.
Differential Diagnosis
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.
Diseases | Symptoms | Physical Examination | Diagnostic tests | Other Findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dyspnea on Exertion | Chest Pain | Hemoptysis | Fever | Tachypnea | Tachycardia | Chest X-ray | ECG | Echocardiography | CT scan and CMR | ||
COVID-19-associated myocarditis | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
|
|
|
Increased cardiac troponins level |
COVID-19-associated heart failure | ✔ | - | ✔ | - | ✔ | ✔ |
|
|
|
|
Increased NT-proBNP and cardiac troponins levels |
COVID-19-associated pneumonia | ✔ | ✔ (Pleuritic) | ✔ | ✔ (Usually high) | ✔ | ✔ |
|
- | Increased inflammatory markers, including ESR, hs-CRP | ||
COVID-19-associated acute respiratory distress syndrome | ✔ | - | ✔ | ✔ | ✔ | ✔ |
|
- |
|
|
- |
COVID-19-associated pulmonary embolism | ✔ (Usually sudden-onset) | ✔ (Pleauritic) | ✔ (If massive PE) | ✔ (Low-grade) | ✔ | ✔ |
|
|
|
|
|